SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
New Drug Reduces One Cause Of Vision Loss, The Scripps Research Institute Study
May 19, 2008
 · 
1 min read
Drug Development
Drug Therapy For PKU Reverses Heart Damage, Johns Hopkins University School of Medicine Study
May 14, 2008
 · 
1 min read
Drug Development
New Immune Treatment May Control AIDS Virus, University of Melbourne Study
May 5, 2008
 · 
1 min read
Drug Development
Australian Scientists Report Weight Loss Breakthrough; Blood Pressure Drug Aid In Weight Loss
April 29, 2008
 · 
1 min read
Drug Development
Spinal Cord Injury Research Hampered By Animal Models, Says New Study
April 28, 2008
 · 
1 min read
Drug Development
Primary Driver Of Stomach Cancer Development Identified, Ludwig Institute For Cancer Research (LICR) Study
April 23, 2008
 · 
1 min read
Drug Development
Pot Plus Alcohol Kills Young Rats’ Brain Cells, Humboldt University, Berlin Study
April 23, 2008
 · 
1 min read
Drug Development
Aida Pharmaceuticals, Inc. Reveals Second Anti-Cancer Drug
April 21, 2008
 · 
1 min read
Drug Development
Prozac Might Cure “Lazy Eye,” Scientists Say
April 18, 2008
 · 
1 min read
Drug Development
Synthetic Vitamin D Helps Prevent Some Breast Cancers, Rutgers University Animal Study Suggests
April 16, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Results of Biomarck Clinical and Preclinical Studies of BIO-11006 in ARDS to be Presented at the 2021 ARDS Drug Development Summit
July 7, 2021
 · 
2 min read
Drug Development
4D pharma Announces Publication of Preclinical Research Showing Single Strain Megasphaera massiliensis improves activity of CAR-T
July 6, 2021
 · 
6 min read
Drug Development
Medolife Rx Announces Successful Stability Results on Escozine Conjugated With Radioactive Iodine
July 1, 2021
 · 
7 min read
Drug Development
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
July 1, 2021
 · 
7 min read
Drug Development
Oyster Point Pharma Announces Preclinical Data Highlighting Potent Activity of OC-01 (varenicline) and OC-02 (simpinicline) Against SARS-CoV-2 Virus and Variants
July 1, 2021
 · 
11 min read
Drug Development
Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data
June 30, 2021
 · 
4 min read
Drug Development
Newly Published Preclinical Data Highlight Broad Immune Activation of Mosaic ImmunoEngineering’s Lead Intratumoral Immunotherapy Candidate, MIE-101
June 29, 2021
 · 
8 min read
Drug Development
PYC Therapeutics Announces Comprehensive Preclinical Results Demonstrating VP-002 Program’s Potential as the First Disease Modifying Therapy for Autosomal Dominant Optic Atrophy
June 29, 2021
 · 
6 min read
Drug Development
Q-State Biosciences Announces Pre-Clinical Proof-of-Concept Data for Exon-Skipping ASO Therapeutic in Ultra-Rare Neurological Disorder
June 28, 2021
 · 
2 min read
Drug Development
RedHill Biopharma’s Opaganib Inhibits COVID-19 Variants in Preclinical Study
June 28, 2021
 · 
10 min read
Drug Development
Lyndra Therapeutics Presents Preclinical Data on Once-Weekly Oral Buprenorphine Treatment, LYN-013, in Development for Opioid Use Disorder
June 25, 2021
 · 
6 min read
Drug Development
Surrozen Presents Data at 2021 International Liver Conference for Wnt-Modulating Antibody SZN-043Company to advance SZN-043 toward first-in-human clinical studies in 2022
June 25, 2021
 · 
9 min read
Drug Development
Arrowhead Presents Preclinical Data on ARO-DUX4 at FSHD Society International Research Congress
June 25, 2021
 · 
6 min read
Drug Development
Revolution Medicines Announces Publication of Scientific Paper Describing Novel Class of Anti-Tumor Compounds Targeting mTORC1
June 24, 2021
 · 
6 min read
Drug Development
BetterLife Secures Mitacs Funding in Collaboration with Carleton University Research Team for TD-0148A Preclinical Depression Studies
June 24, 2021
 · 
5 min read
Drug Development
Hesperos Validates Utility of Human-on-a-Chip® Approach to Model Nonalcoholic Fatty Liver Disease
June 23, 2021
 · 
5 min read
Drug Development
Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology
June 23, 2021
 · 
5 min read
Drug Development
Cybin Announces Completion of its 51st Pre-Clinical Psychedelic Molecule Study
June 22, 2021
 · 
4 min read
Business
NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410
June 21, 2021
 · 
6 min read
Drug Development
Kymera Therapeutics Presents New Preclinical Data for its IRAKIMiD Degrader KT-413 Demonstrating Strong Antitumor Activity as Both Monotherapy and in Combination in MYD88-mutant Lymphoma Models
June 21, 2021
 · 
7 min read
Load More